Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta Carotene for Crohn's Disease in Remission
NCT00275418Phase 3Unknown
- Sponsor
- Bnai Zion Medical Center
- Start
- Jul 2002
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Crohn's disease comparing Beta Carotene with Placebo (2 arms). Primary endpoints: Crohn's Disease Activity Index at 12 months and Rate of Crohn's Disease Exacerbation at 1 year. Status: unknown.
02
Drugs
beta-carotene
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00275418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00275418.